Etiopathogenesis of primary sclerosing cholangitis

被引:61
作者
Chapman, Roger [1 ]
Cullen, Sue [1 ]
机构
[1] John Radcliffe Hosp, Dept Gastroenterol, Oxford OX3 9DU, England
关键词
autoantibody; immunogenetics; biliary epithelial cells; T cell receptor; lymphocytes;
D O I
10.3748/wjg.14.3350
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology but lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for this disease. Associations with inflammatory bowel disease (IBD) especially ulcerative colitis (UC), and with particular autoimmune diseases, as well as the genetic associations further suggest PSC may be an immune-mediated disease. The immunogenetics of PSC have been the subject of active research and several HLA and non-HLA associated genes have been implicated in the development of the disease. Lymphocytes derived from the inflamed gut may enter the liver via the enterohepatic circulation to cause hepatic disease. PSC may be triggered in genetically susceptible individuals by infections or toxins entering the portal circulation through a permeable colon and hence evoking an abnormal immune response. (c) 2008 The WJG Press. All rights reserved.
引用
收藏
页码:3350 / 3359
页数:10
相关论文
共 86 条
  • [1] AADLAND E, 1987, SCAND J GASTROENTERO, V22, P655, DOI 10.3109/00365528709011139
  • [2] Serum autoantibodies in patients with primary sclerosing cholangitis
    Angulo, P
    Peter, JB
    Gershwin, ME
    DeSotel, CK
    Shoenfeld, Y
    Ahmed, AEE
    Lindor, KD
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 (02) : 182 - 187
  • [3] Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: A comparison of the alkaline phosphatase and immunofluorescent techniques
    Bansi, DS
    Bauducci, M
    Bergqvist, A
    Boberg, K
    Broome, U
    Chapman, R
    Fleming, K
    Jorgensen, R
    Lindor, K
    Rosina, F
    Schrumpf, E
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (06) : 575 - 580
  • [4] Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis
    Bernal, W
    Moloney, M
    Underhill, J
    Donaldson, PT
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (02) : 237 - 241
  • [5] Björnsson ES, 2000, HEPATO-GASTROENTEROL, V47, P1504
  • [6] ADHESION MOLECULE EXPRESSION IN PRIMARY SCLEROSING CHOLANGITIS AND PRIMARY BILIARY-CIRRHOSIS
    BLOOM, S
    FLEMING, K
    CHAPMAN, R
    [J]. GUT, 1995, 36 (04) : 604 - 609
  • [7] Tumour necrosis factor α impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis
    Bo, X
    Broome, U
    Remberger, M
    Sumitran-Holgersson, S
    [J]. GUT, 2001, 49 (01) : 131 - 141
  • [8] Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis
    Bowlus, Christopher L.
    Karlsen, Tom H.
    Broome, Ulrika
    Thorsby, Erik
    Vatn, Morten
    Schrumpf, Erik
    Lie, Benedicte A.
    Boberg, Kirsten Muri
    [J]. JOURNAL OF HEPATOLOGY, 2006, 45 (05) : 704 - 710
  • [9] A STUDY OF LIVER DISORDER IN ULCERATIVE COLITIS
    BROOKE, BN
    WALKER, FC
    DYKES, PW
    CHIR, M
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1961, 37 (427) : 245 - &
  • [10] DISTRIBUTION OF HLA-DR, HLA-DP, HLA-DQ ANTIGENS IN LIVER-TISSUE FROM PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    BROOME, U
    GLAUMANN, H
    HULTCRANTZ, R
    FORSUM, U
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1990, 25 (01) : 54 - 58